Avenoso Angela, D'Ascola Angela, Scuruchi Michele, Mandraffino Giuseppe, Campo Salvatore, Campo Giuseppe M
Department of Biomedical and Dental Sciences and Morphofunctional Images, Policlinico Universitario, University of Messina, 98125 - Messina, Italy.
Department of Clinical and Experimental Medicine, University of Messina, Policlinico Universitario, 98125 Messina, Italy.
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129731. doi: 10.1016/j.bbagen.2020.129731. Epub 2020 Sep 12.
Small HA fragments are produced during cartilage degradation and their role seems to be preponderant during pathologies in which cartilage injury contribute to trigger and perpetuate the inflammatory mechanism. Several reports have increasingly shown that MicroRNAs (miRs), a small non-coding mRNAs are involved in the regulation of multiple biological processes, including cell proliferation and inflammation response in different pathologies, among them miR146a seems to be involved in inflammatory processes.
Starting by these evidences we investigated the levels of miR146a and its correlation with inflammatory mediators in an experimental model of 6-mer HA-induced inflammatory response in human cultured chondrocytes.
Treatment of chondrocytes with 6-mer HA showed up-regulation in inflammation parameters such as TLR-4, and CD44 receptors activation, IL-6, IL-1β and MMP-13 mRNA expression and proteins production, as well as NF-kB activation. We also revealed an up-regulation of miR146a. Transfection with a miR146a mimic or miR146a inhibitor produced the following effects: chondrocytes receiving miR146a mimic and then 6-mer HA significantly reduced inflammatory cytokines and MMP-13, while exposition of chondrocytes with miR146a inhibitor and then the 6-mer HA incremented the activity of damaging cytokines and MMP13. Expression of CD44 receptor was not affected by miR-146a treatments, while TLR-4 expression and NF-kB activation were modified.
We concluded that up-regulation of miR146a occurred in 6-mer HA-induced inflammation response may reduce the inflammatory cascade by modulating TLR-4 and NF-kB activation.
These results could be useful in develop new therapeutic strategies with the aim to reduce OA and RA incidence.
小的透明质酸(HA)片段在软骨降解过程中产生,在软骨损伤引发并维持炎症机制的病理过程中,其作用似乎至关重要。越来越多的报道表明,微小RNA(miR),一种小的非编码mRNA,参与多种生物学过程的调控,包括不同病理状态下的细胞增殖和炎症反应,其中miR146a似乎参与炎症过程。
基于这些证据,我们在人培养软骨细胞的6聚体HA诱导的炎症反应实验模型中,研究了miR146a的水平及其与炎症介质的相关性。
用6聚体HA处理软骨细胞显示炎症参数上调,如TLR-4和CD44受体激活、IL-6、IL-1β和MMP-13 mRNA表达及蛋白产生,以及NF-κB激活。我们还发现miR146a上调。用miR146a模拟物或miR146a抑制剂转染产生了以下效果:接受miR146a模拟物然后6聚体HA处理的软骨细胞显著降低了炎性细胞因子和MMP-13,而用miR146a抑制剂处理然后6聚体HA处理的软骨细胞增加了损伤性细胞因子和MMP13的活性。CD44受体的表达不受miR-146a处理的影响,而TLR-4表达和NF-κB激活发生了改变。
我们得出结论,在6聚体HA诱导的炎症反应中发生的miR146a上调可能通过调节TLR-4和NF-κB激活来减少炎症级联反应。
这些结果可能有助于开发新的治疗策略,以降低骨关节炎和类风湿关节炎的发病率。